V

Viking Therapeutics
D

VKTX

42.270
USD
0.78
(1.88%)
Market Closed
Volume
340,367
EPS
-1
Div Yield
-
P/E
-45
Market Cap
4,710,415,952
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    6.675
    (2.79%)
    245.505 USD
    AMGN
    AMGN
    2.27
    (0.87%)
    263.46 USD
    A
    ARWR
    -0.020
    (-0.10%)
    19.450 USD
    C
    CRBP
    -0.370
    (-2.78%)
    12.960 USD
    GILD
    GILD
    1.460
    (1.60%)
    92.570 USD
    G
    GNFT
    0.00000
    (0.00%)
    3.81000 USD
    GSK
    GSK
    0.155
    (0.46%)
    33.595 USD
    I
    ICPT
    0.000000
    (0.00%)
    0.000000 USD
    More
News

Title: Viking Therapeutics

Sector: Healthcare
Industry: Biotechnology
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.